Related Experiment Videos
[Transurethral microwave thermotherapy for benign prostatic hyperplasia]
M Tokumitsu1, M Mizunaga, S Kaneko
1Department of Urology, Asahikawa Medical College.
Summary
Transurethral microwave thermotherapy (TUMT) effectively improved symptoms and urinary flow in benign prostatic hyperplasia (BPH) patients. This safe, single-session treatment offers a valuable option for BPH management, even for those unsuitable for surgery.
Area of Science:
- Urology
- Minimally Invasive Therapies
Context:
- Benign prostatic hyperplasia (BPH) is a common condition affecting aging men.
- Current treatments for BPH include medication, transurethral resection of the prostate (TUR-P), and minimally invasive procedures.
- Transurethral microwave thermotherapy (TUMT) presents an alternative therapeutic option.
Purpose:
- To evaluate the clinical efficacy and safety of transurethral microwave thermotherapy (TUMT) using the Endotherm UMW system in patients with benign prostatic hyperplasia (BPH).
Summary:
- A single 1-hour session of TUMT was performed on 28 BPH patients.
- Efficacy was assessed via International Prostate Symptom Score (I-PSS), QOL score, peak urinary flow rate (Qmax), average flow rate (Qave), residual urine volume, and prostate volume.
- Significant improvements in I-PSS, QOL, Qmax, and Qave were observed at 24 weeks post-treatment.
Impact:
- TUMT demonstrated significant improvements in urinary symptom scores and flow rates.
- The procedure was found to be safe and useful for symptomatic BPH patients, including those unsuitable for TUR-P.
- Successful catheter removal was noted in patients with pre-existing urinary retention.